Spermine
and spermidine serve as the key biomarkers for early-stage
cancer diagnosis. This work reports a rapid, highly selective, and
noninvasive sensing platform for spermine/spermidine. The hybrid material,
developed in this work, has been characterized by UV–vis, IR,
powder XRD, SEM, EDX, and rheological studies. Storage modulus (G′) and loss modulus (G″)
measurements infer that embedding boronic acid integrated coumarin
softens the agarose gel fibers at room temperature. Stress resistance
measurement and subsequent imaging further confirms the softness of
the hybrid hydrogel over pure agarose gel and homogeneous distribution
of the dye in the hybrid matrix as well. The soft hydrogel with a
limit-of-detection (LOD) value of 6 μM showed a nearly 27-fold
fluorescence enhancement for spermine. The hybrid hydrogel matrix
can be useful within a wide concentration window (6 μM–2.5
mM spermine). Response time (≤7 s) confirms rapid detection
ability of the material. Noninterference from various metal ions,
common anions, monosaccharides, nucleobases, and amino acids, particularly,
histidine, arginine, lysine, ornithine, glutamine, etc., makes
the hybrid hydrogel suitable for the real-time measurement of spermine
in human urinary and blood samples. Furthermore, noninterference from
other biogenic amines supports the highly selective nature of the
hybrid gel. The ability to measure spermine in urinary samples by
the probe offers a noninvasive nature of the sensing platform. Overall,
we envisioned that the hybrid material formulation would be useful
for diagnosing early-stage tumors and assessing the recovery of patients
undergoing chemotherapeutic treatment.